Cholestasis correlates with higher DPPIV activity and higher IP-10 serum levels in patients with chronic hepatitis C
M Rau, J Schmitt, P Frei, K Spanaus, B Müllhaupt, A Geier · Zeitschrift für Gastroenterologie · 2013 · Heft 01
Bibliografische Angaben
Zusammenfassung
Background: A significant proportion of end stage liver disease is caused by chronic hepatitis C (HCV) infection. Studies have shown that high baseline interferon-gamma-inducible protein-10 (IP-10) concentration correlates with nonresponse to peginterferon/ribavirin therapy and with first and second phase viral kinetics in patients with chronic hepatitis C infection. IP-10 serum concentrations are good surragete parameters for intrahepatic induction of interferon stimulated gene (ISG) activation. Recently higher IP-10 serum concentrations were described as antagonist forms of IP-10 cleaved by DPPIV (Casrouge et…